Using storytelling to combat the prescription opioid abuse epidemic

March 3, 2014 by Jessica Mikulski

(Medical Xpress)—In the fight against a nationwide prescription opioid abuse epidemic, Penn Medicine researchers are using storytelling to help doctors recall important, potentially lifesaving national guidelines on how to prescribe these medications.

The story they are testing begins with a man named Frank, a friendly, middle-aged man who came to a crowded emergency room complaining of back pain that he said didn't get better despite use of hot packs, Advil, and massages from his wife. His doctor is unable to access her state's prescription drug monitoring program to check if he already had prescriptions for pain pills, but follows recommended guidelines for giving him low doses of opioids for a short time, until he could visit his regular doctor. Only later did she learn he had been visiting several other EDs in recent months, walking away with Percocet from each one – a red flag that he may be misusing these opioid prescriptions.

The team of researchers from the Department of Emergency Medicine at the Perelman School of Medicine found that physicians who heard this narrative, or story, about opioid guidelines were more likely to recall the guideline content after an hour than those who just heard a summary of the guidelines. The new study is published online ahead of print in the journal Academic Emergency Medicine.

Opioid overdose is the second leading cause of unintentional injury death in the U.S., and many of these fatalities can be attributed to patients taking too much a legally prescribed pain medication. Nearly half of patients presenting to an emergency department (ED) have painful conditions, yet emergency patients are also considered at high risk for opioid abuse. To deliver patient-centered care, emergency physicians are often challenged to identify – during only brief interactions – the best pain regimens to prescribe. In order to better help clinicians identify patients who most need prescriptions, the American College of Emergency Physicians (ACEP) published an evidence-based clinical policy in October 2012 outlining optimal pain management in the ED.

"Evidence-based guidelines can be valuable tools for providers and incorporate the best clinical research findings to help direct appropriate care for patients. The problem is, many physicians don't readily adopt guidelines, creating an unfortunate barrier between rigorous medical research and the day-to-day practice of medicine," said senior study author Zachary Meisel, MD, MPH, MSc, assistant professor of Emergency Medicine in the Center for Emergency Care Policy Research and a senior fellow at the Leonard Davis Institute of Economics at Penn. "From previous research, we know that narratives in medicine serve as a powerful tool for translating and communicating complex ideas to patients, so we wanted to know if this same approach could help doctors better recall and relate crucial care-related protocols when it comes to prescription opioids."

To test this innovative approach, the research team conducted a prospective, randomized controlled experiment to compare whether a short narrative versus a summary of clinical guidelines promoted short-term recall of six themes contained in the ACEP opioid guideline with 82 clinicians from across Philadelphia.

The experiment was modeled after the free-recall test, an established technique in studies of memory. Emergency physicians were randomized to read either a summary of the guideline or a narrative. The fictional narrative was constructed to match the summary in content and length. One hour after reading the text, participants listed all content that they could recall.

"In medical school we are taught, and often rightly so, to be wary of anecdote when making decisions about patient care. So we didn't know what we would find. But we believe that doctors are people too—so why couldn't stories be helpful for doctors who need to integrate and use evidence-based information all the time?" asked Meisel.

Physicians exposed to the narrative about opioid guidelines were more likely to recall specific components of the guideline content at one hour than those exposed to a summary of the . For some components, the increased rate of recall among the story group was as high as three times the rate of the summary. For three of the six themes, the proportion of responses that recalled the theme was significantly greater in the narrative arm compared to the summary arm, with the differences ranging from 20 to 51 percent. Additionally, the research team found that in the guideline summary arm, 54 percent of responses were found to contain falsely recalled or extraneous information versus 21 percent of responses in the narrative arm.

Explore further: ACEP: Characteristics of patients with opioid overdose

More information: "Evidence‐based Narratives to Improve Recall of Opioid Prescribing Guidelines: A Randomized Experiment." Austin S. Kilaru, et al. Academic Emergency Medicine. First published: 20 February 2014Full publication history. DOI: 10.1111/acem.12326

Related Stories

ACEP: Characteristics of patients with opioid overdose

October 18, 2013
(HealthDay)—Characteristics associated with opioid overdose and doctor-shopping (utilizing more than 10 providers for schedule II to V medications over a one-year period) have been identified, according to two studies presented ...

Guidelines agree on opioid risk mitigation strategies

November 13, 2013
(HealthDay)—Recent guidelines on chronic pain management agree on several opioid risk mitigation strategies, according to a review published online Nov. 12 in the Annals of Internal Medicine.

Emergency physicians use new tool to detect drug-seekers in the ER

July 10, 2013
Emergency physicians and other emergency department staff were fairly accurate in assessing which patients were drug-seekers in the emergency department, changing their prescribing plans for less than 10 percent of patients ...

ER study finds one in ten older teens misuse Rx painkillers, sedatives (Update)

October 28, 2013
With prescription drug abuse at epidemic levels nationwide, and overdoses killing more people than auto accidents in many states, a new University of Michigan study provides striking new data about the misuse of potent prescription ...

Health care workers trained on Rx drug abuse

November 7, 2013
(Medical Xpress)—A Colorado health care training course designed to curb prescription drug abuse, reports preliminary data that state-wide chronic pain prescription practices are changing since first offering the training ...

Recommended for you

Fighting opioid addiction in primary care—new study shows it's possible

October 18, 2017
For many of the 2 million Americans addicted to opioids, getting good treatment and getting off prescription painkillers or heroin may seem like a far-off dream.

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.